CNS Neuroscience & Therapeutics

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

CNS NEUROSCI THER

ISSN / eISSN

1755-5930 / 1755-5949

Aims and Scope

CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.

Subject Area

NEUROSCIENCES

PHARMACOLOGY & PHARMACY

CiteScore

9.60

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Pharmacology (medical)	Q1	#20/260
Medicine - Psychiatry and Mental Health	Q1	#41/531
Medicine - Physiology (medical)	Q1	#13/102
Medicine - Pharmacology	Q1	#44/301

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
NEUROSCIENCES - SCIE	Q1
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

Country/Area of Publication

ENGLAND

Publisher

Wiley-Blackwell Publishing Ltd

Publication Frequency

Quarterly

Year Publication Started

2008

Annual Article Volume

223

Open Access

YES

Contact

WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Popular journals in the same field
Recent articles

A TTC19 mutation associated with progressive movement disorders and peripheral neuropathy: Case report and systematic review: (2023) Xianjun Xuan, Jie Ruan, Chunhong Wu, Yiyi Gao, Lingfei Li, Xiaoguang Lei

Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell‐derived secretome in preclinical models of morphine dependence: (2023) Mauricio Quezada, Carolina Ponce, Pablo Berríos‐Cárcamo, Daniela Santapau, Javiera Gallardo, Cristian De Gregorio, María Elena Quintanilla, Paola Mora...

Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression: (2023) Sixin Li, Dong Yang, Xuhui Zhou, Lu Chen, Lini Liu, Ruoheng Lin, Xinyu Li, Ying Liu, Huiwen Qiu, Hui Cao, Jian Liu, Quan Cheng

Remote ischemic conditioning after stroke: Research progress in clinical study: (2023) Bin Jiang, Xiaojie Wang, Jianping Ma, Aminah Fayyaz, Li Wang, Pei Qin, Yuchuan Ding, Xunming Ji, Sijie Li

Novel subsets of peripheral immune cells associated with promoting stroke recovery in mice: (2023) Yichen Gu, Xiaotao Zhang, Huaming Li, Rui Wang, Chenghao Jin, Junjie Wang, Ziyang Jin, Jianan Lu, Chenhan Ling, Fangjie Shao, Jianmin Zhang, Ligen Shi

Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease: (2023) Feng‐Dan Zhu, Bin‐Ding Wang, Da‐Lian Qin, Xiao‐Hui Su, Lu Yu, Jian‐Ming Wu, Betty Yuen‐Kwan Law, Min‐Song Guo, Chong‐Lin Yu, Xiao‐Gang Zhou, An‐Guo Wu

Perspective from single‐cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental?: (2023) Xinpeng Deng, Ziliang Hu, Shengjun Zhou, Yiwen Wu, Menglin Fu, Chenhui Zhou, Jie Sun, Xiang Gao, Yi Huang

Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms: (2023) Mehraveh Sadeghi Ivraghi, Mohammad Yasin Zamanian, Reena Gupta, Harun Achmad, Hashem O. Alsaab, Ahmed Hjazi, Rosario Mireya Romero‐Parra, Enas R. Alwa...

Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics: (2023) Christian Griñán‐Ferré, Júlia Jarné‐Ferrer, Aina Bellver‐Sanchís, Sandra Codony, Dolors Puigoriol‐Illamola, Coral Sanfeliu, Yumin Oh, Seulki Lee, Sant...

Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study: (2023) Yusha Cui, Dongning Su, Junjiao Zhang, Joyce S. T. Lam, Shuangshuang Cao, Yaqin Yang, Yingshan Piao, Zhan Wang, Junhong Zhou, Hua Pan, Tao Feng

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

Hello, may I ask if you will be submitting again in the old system? I also submitted my manuscript from the new system. I checked the "Author's Note" in the old system, which stated that if you submitted from the new system, you need to exit "ScholarOne Manuscripts" and return to the "Research Exchange" system. So, I'm not sure if I need to submit again.

2023-01-26

I tell you, if you go into the old system again, you will find a column called "Author". On the left side, there is a section called "Submitted Manuscripts" where you can find the manuscripts you have submitted. Follow the steps there to submit and you will receive a manuscript number and an email.

2022-12-10

View All Reviews

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started